TOP
Ninja Kattenbeck (Psychotherapist)
The evolution of depression treatments reflects changing theories about the causes of mental illness, ranging from supernatural influences to psychological and biological factors. Knowing how depression was thought of in the past can help understanding the present research and future developments. After an overview of the historical development of depression therapy, this article explores the state of the art of modern treatment, with the two main pillars of antidepressant medication and psychotherapy. We’ll end with some thoughts about the future of depression treatment.
A growing body of scientific evidence suggests a positive relationship between microdosing psychedelic drugs and an improvement of mental disorders such as depression. This article explores which drugs are commonly used for microdosing, how they work and the potential benefits and challenges they present. Further research needs to confirm safety and long-term effects.
As the landscape of Life insurance continues to evolve, underwriters are increasingly encountering new and complex factors that influence risk assessment. One such emerging trend is the practice of microdosing psychedelics. While the scientific evidence and potential benefits and risks have been thoroughly discussed in the previous article, this text will focus on the broader implications and practical considerations for underwriters.
When talking about mental health disorders it is important to make the distinction between a person’s fluctuating state of mental wellbeing and the presence of a mental illness, as well as the interplay between them. This article illustrates concepts and models associated with mental health and mental wellbeing and summarises key take-aways for underwriting mental disorders.
